Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING
Bonafide funds controls a total of 79,614,756 A-shares in Hofseth BioCare ASA corresponding to approx. 20.15% of total outstanding A-shares and approx. 19.37% of total shares in HBC.This information is subject to the disclosure requirements pursuant to sections 4-2 and 5-12 of the Norwegian Securities Trading Act and article 19 of the EU Market Abuse Regulation.
Articolo Precedente
Articolo Successivo
Today,
(informazione.it - comunicati stampa - cibi e bevande)
![](https://www.globenewswire.com/newsroom/ti?nf=MTAwMDkzMzMwOCM0MDE4MTQ2MzEjMjAwMTA1Ng==)
Bonafide funds controls a total of 79,614,756 A-shares in Hofseth BioCare ASA corresponding to approx. 20.15% of total outstanding A-shares and approx. 19.37% of total shares in HBC.
This information is subject to the disclosure requirements pursuant to sections 4-2 and 5-12 of the Norwegian Securities Trading Act and article 19 of the EU Market Abuse Regulation.
![](https://ml-eu.globenewswire.com/media/MWFjNzRlNWMtNDc5OS00ZDVkLTkzODgtOGUxOGUwNGIyOTg4LTEwMTI2Mjk=/tiny/Hofseth-Biocare-ASA.png)
Per maggiori informazioni
Sito Web
h-bc.no
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti